Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors
about
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON studyRandomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers.Patient responses to genetic information: studies of patients with hereditary cancer syndromes identify issues for use of genetic testing in nephrology practice.Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment.Effect of genetic counseling and testing for BRCA1 and BRCA2 mutations in African American women: a randomized trial.Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.BRCA1/2 genetic testing uptake and psychosocial outcomes in men.Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer.BRCA mutation testing in determining breast cancer therapy.Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillanceLong-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research.Engagement and communication among participants in the ClinSeq Genomic Sequencing Study.Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer.Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.How Informed Is the Decision About Breast Reconstruction After Mastectomy?: A Prospective, Cross-sectional Study.Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers.Decision making for breast cancer prevention among women at elevated riskSociety of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.The psychosocial impact of contralateral risk reducing mastectomy (CRRM) on women: A rapid review.Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.Adaptation of couples living with a high risk of breast/ovarian cancer and the association with risk-reducing surgery.Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial.
P2860
Q30896495-B3BCC3EE-1626-411F-8EC4-A76A7F253D96Q33768504-CBD4AE03-0612-4A1A-90CE-B5B0C48DAF8BQ33780087-524E3581-A553-45DF-9834-AA535B6295F5Q34358066-1D48CDBB-89A1-4E5D-8704-07E9B77F1CB4Q34515660-2CF90CEF-E474-4E74-BEC6-197D19E6BB00Q34527229-1A859EDE-8799-41CA-8F79-478E7DAE5B71Q34944244-6387B646-8B1D-4BFC-A8D7-D9A51B1B369AQ35131147-C9315AB0-E255-405B-98EE-7B653CE53A54Q35584662-B4BB65FE-E131-44B0-ADED-4BBD33D599D3Q35619225-7FC1CAF7-599F-4EE0-AA0E-5D55FFC6BF27Q35777905-EB4458A7-23D3-400D-815D-AD3301C94A16Q35815469-A020EF48-F0B2-44D9-ACBA-FE1A5498AB49Q37131303-4A455A15-354F-4D4D-A59C-AEF589E0F298Q37151892-3FA3AB83-DCAC-4AC0-9FE2-D3A2A3EC5071Q37387444-F0988135-3863-4804-B885-98C1D5507FF2Q37578172-CBE200B5-E523-4E24-B999-35EC377C316BQ37661126-818A4173-BB7B-47B5-A79C-39F4F86E7304Q37669779-CCFCA6CB-C72D-4AA3-B0D9-EEF189333B6EQ37677168-7DAEC7F6-D1B3-4430-9A06-E64D9D38E321Q37688802-9D2E442D-9616-433B-8A37-5C7E96EA1910Q37720955-0516FEFF-D863-48A4-B71E-B6C58652803FQ39033804-361F3135-AA7F-4AE7-9822-946AB4262C1AQ39270145-7C4A176A-79FD-4500-BD9A-A32FF253B9F1Q46044304-205B3ED5-D5AD-4EEB-B466-F3376D050037Q47585612-44D67F9A-C079-4D07-8761-55B78FEFB754Q48329892-C87A29F4-3711-4445-B35D-C2495041CBE0
P2860
Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Predictors and outcomes of con ...... among breast cancer survivors
@ast
Predictors and outcomes of con ...... among breast cancer survivors
@en
Predictors and outcomes of con ...... among breast cancer survivors
@nl
type
label
Predictors and outcomes of con ...... among breast cancer survivors
@ast
Predictors and outcomes of con ...... among breast cancer survivors
@en
Predictors and outcomes of con ...... among breast cancer survivors
@nl
prefLabel
Predictors and outcomes of con ...... among breast cancer survivors
@ast
Predictors and outcomes of con ...... among breast cancer survivors
@en
Predictors and outcomes of con ...... among breast cancer survivors
@nl
P2093
P2860
P1476
Predictors and outcomes of con ...... among breast cancer survivors
@en
P2093
Beth N Peshkin
Chanita H Halbert
Kristi D Graves
Marc D Schwartz
Tiffani A DeMarco
P2860
P2888
P304
P356
10.1007/S10549-006-9423-5
P407
P577
2006-10-26T00:00:00Z
P5875
P6179
1023414518